Navigation Links
Alexza to Announce 2008 Financial Results and Update Its Clinical Pipeline on Tuesday, March 10, 2009
Date:3/6/2009

e Company's technology, the Staccato(R) system, vaporizes unformulated drug to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience.

Alexza's lead program is AZ-004 (Staccato loxapine) and is being developed for the acute treatment of agitation in schizophrenic or bipolar disorder patients. Alexza has completed and announced positive results from both of its AZ-004 Phase 3 clinical trials, and is projecting a New Drug Application submission in early 2010. The Company has completed an end-of-Phase 2 meeting with the FDA for AZ-001 (Staccato prochlorperazine), and it has advanced AZ-104 (Staccato loxapine) into Phase 2b testing, both product candidates being developed for the acute treatment of migraine headache. AZ-002 (Staccato alprazolam) has completed Phase 1 testing and a Phase 2a proof-of-concept clinical trial. Product candidates that have completed Phase 1 testing are AZ-003 (Staccato fentanyl) for the treatment of breakthrough pain and AZ-007 (Staccato zaleplon) for the treatment of insomnia. More information, including this and past press releases from Alexza, is available online at www.alexza.com.

Safe Harbor Statement

The anticipated news release and conference call will contain forward-looking statements that involve significant risks and uncertainties. Any statement describing the Company's expectations or beliefs is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of 1995, and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of developing and com
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Alexza Pharmaceuticals Promotes Peter D. Noymer, PhD to Vice President, Product R&D
2. Alexza Pharmaceuticals Announces Upcoming Conference Participation and Webcasts
3. Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates
4. Alexza to Announce 2008 Third Quarter Financial Results and Update Its Clinical Pipeline on Thursday, November 6, 2008
5. Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations
6. Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd.
7. Carlos A. Parra Joins Alexza Pharmaceuticals as Vice President, Quality
8. Alexzas Corporate Presentation to be Webcast at the Seventh Annual JMP Securities Research Conference and the 2008 Citi Investment Research Global Healthcare Conference
9. Alexza to Webcast Investor and Analyst Day Presentations
10. Alexza Secures $50 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd.
11. Alexzas Corporate Presentation to be Webcast at the Cowen & Company 28th Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... New Brunswick (PRWEB) March 05, 2015 ... help validate product innovations as the company prepares to ... will be comprised of individuals in the Life Sciences ... working with our clients,” said Elandas CEO Ryan Roberts. ... as a successful organization through our collaborative efforts. As ...
(Date:3/4/2015)... 05, 2015 Understanding China’s New Medical ... p.m. – 3:00 p.m. EDT, http://www.fdanews.com/UnderstandingChinaMDRegs , ... regulations for medical devices in China. , These ... — research and development, approval, manufacturing, distribution, and post-market ... currently in development as well as those that are ...
(Date:3/4/2015)... March 04, 2015 In the Ultimate Fighting ... that is the main event. For UFC 189 , ... will be for the UFC Featherweight Championship. Brazilian champion Jose ... out-spoken native of Ireland, Conor “Notorious” McGregor. UFC 189 will ... Arena in Las Vegas, NV. , When it comes to ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 When people talk ... the top artists spread across numerous genres, the Houston ... the conversation. Each night during the annual livestock show and ... addition to the other activities being held at the event. ... groups of performers that will try and get the festival ...
(Date:3/4/2015)... 2015 TROY Healthcare Solutions will be ... the ultimate level of security for prescriptions, in Houston, ... Plaza Medical Center located at 6633 Travis Street from ... 7 AM, TROY Healthcare Solutions will host a continental ... offer brief presentations each hour to introduce attendees to ...
Breaking Medicine News(10 mins):Health News:Elandas Creates Advisory Board to Help Guide Innovation 2Health News:FDAnews Announces: Understanding China’s New Medical Device Regulations Webinar, March 26, 2015 2Health News:FDAnews Announces: Understanding China’s New Medical Device Regulations Webinar, March 26, 2015 3Health News:Cheap UFC 189 Tickets: Jose Aldo vs. Conor McGregor UFC 189 Ticket Prices Slashed by Ticket Down for Featherweight Title 2Health News:Cheap UFC 189 Tickets: Jose Aldo vs. Conor McGregor UFC 189 Ticket Prices Slashed by Ticket Down for Featherweight Title 3Health News:Cheap Houston Rodeo Tickets: Ticket Down Slashes Houston Rodeo Tickets for John Legend, Pitbull, Alan Jackson, Tim McGraw, Zac Brown Band, Fall Out Boy & Miranda Lambert 2Health News:Cheap Houston Rodeo Tickets: Ticket Down Slashes Houston Rodeo Tickets for John Legend, Pitbull, Alan Jackson, Tim McGraw, Zac Brown Band, Fall Out Boy & Miranda Lambert 3Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 2Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 3
... allergic reactions, other problems have surfaced with dermal fillers ... health advisers were taking a closer look Tuesday at ... help to smooth away deep lines and wrinkles on ... rare, the U.S. Food and Drug Administration has received ...
... developed by Mitchell Sogin of the Marine Biological Laboratory ... completed the most precise survey to date of how ... treatment. , Sogin, director of the MBL,s Josephine Bay ... with David Relman and Les Dethlefsen of Stanford University, ...
... - A study of patients, at the Christie Hospital, ... care depends more on where the patient lives, than ... "postcode lottery" since each decision is made solely by ... of this study are published in a letter to ...
... over frail elderly, experts say , , TUESDAY, Nov. 18 (HealthDay ... to helpful, uncomplaining robots to fill the worrisome "care gap" ... called the uBOT-5, is already capable of carrying out simple ... can even spot trouble -- such as a person falling ...
... Leading Provider of Supplemental Insurance Offers Cancer Policies ,to Help Offset ... ... Chicago, IL (PRWEB) November 18, 2008 -- November is Lung Cancer ... supplemental insurance, encourages consumers to consider the financial impact that lung ...
... Latina women who prefer speaking Spanish are more ... dissatisfaction with their breast cancer treatment, according to a ... Comprehensive Cancer Center. , Despite receiving similar treatment, Latina ... to report high levels of dissatisfaction and regret about ...
Cached Medicine News:Health News:FDA Takes Closer Look at Wrinkle Treatments 2Health News:Antibiotics can cause pervasive, persistant changes to microbiota in human gut 2Health News:A postcode lottery still exists for cancer patients with 'exceptional circumstances' 2Health News:Robots May Come to Aging Boomers' Rescue 2Health News:Robots May Come to Aging Boomers' Rescue 3Health News:Robots May Come to Aging Boomers' Rescue 4Health News:Combined Insurance Encourages Consumers to Assess Insurance Plans and Protection During Lung Cancer Awareness Month 2Health News:Combined Insurance Encourages Consumers to Assess Insurance Plans and Protection During Lung Cancer Awareness Month 3
(Date:3/4/2015)... The March 3, 2015, order from the Federal Drug Administration ... labels to clarify the drugs, intended use and warn about ... to protect the public from injury from these products, according ... Hanly Conroy . The order says that the ... currently taken by millions of U.S. men – are approved ...
(Date:3/4/2015)... Minn. , March 4, 2015   Mayo ... an agreement to develop the next generation of wearable ... "We are hoping that this technology will be game-changer. ... and diabetes," says James Levine, M.D., Ph.D. , ... "They are accurate, inexpensive, and can be integrated into ...
(Date:3/4/2015)... Following the reintroduction of the Comprehensive ... released a report today urging policymakers to take ... epidemic through more effective use of medication-assisted treatment ... for Expanding Access to Medication-Assisted Treatment to Address ... justice, and economic advantages of medication-assisted treatment along ...
Breaking Medicine Technology:Simmons Hanly Conroy, LLC: FDA Orders Label Warnings on Testosterone Drugs Concerning Normal Aging Use and Heart Attack-Stroke Risks 2Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 2Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 3Improved Medication-Assisted Treatment Policy Could Aid Epidemic of 20 Million Americans with Untreated Addiction 2
... DIEGO, May 4, 2011 Volcano Corporation (NASDAQ: ... precision intravascular diagnosis and therapy guidance tools designed to ... said today that it will be participating in the ... Wednesday, May 11. The presentation by Scott ...
... Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX ), ... commercialization of medically important pharmaceutical products for the treatment ... today announced the pricing of an underwritten registered offering ... price of $4.70 per share. The aggregate ...
Cached Medicine Technology:Keryx Biopharmaceuticals, Inc. Prices Common Stock Offering 2
... The Nellcor N-20PA Handheld Pulse Oximeter ... dependability. The durable construction of the N-20PA ... extreme temperatures and conditions it has ... It is conveniently portable for spot check ...
... Nellcor NPB-290 and NPB-295 Pulse Oximeters ... provide accuracy, reliability and proven signal ... poorly perfused patients. Equipped with Oxismart ... Technology, these pulse oximeters identify electronic ...
... the growing portfolio of OxiMax® monitors, ... a compact, affordable bedside monitor. Equipped ... technology, it offers reliable operation during ... with the complete family of innovative ...
The Model 5305 is a hand-held, portable, lightweight pulse oximeter designed for spot checking. It has a NiCad rechargeable battery....
Medicine Products: